Critical Warnings & Restrictions In Canada

Basic Gluconorm Information

• INN (International Nonproprietary Name): Repaglinide
• Brand Names Available In Canada (English): Gluconorm (tablets) by Novo Nordisk; other international brands include Prandin and NovoNorm.
• ATC Code: A10BX02
• Forms & Dosages: Tablets 0.5 mg, 1 mg, 2 mg
• Manufacturers In Canada (English): Novo Nordisk
• Registration Status In Canada (English): Approved by Health Canada as Gluconorm
• OTC / Rx Classification: Prescription only (Rx)

Immediate Safety Priorities For Canadian Patients

Are you worried about low blood sugar after a meal or a missed snack?

Hypoglycaemia is the most important immediate risk with repaglinide.

Repaglinide works quickly at mealtimes and can cause low blood sugar if a meal is missed or delayed.

Always carry a fast-acting glucose source such as glucose tablets, juice, or candy.

Know the common warning signs so you can act fast.

• Warning Signs Checklist: Sweating.
• Tremor.
• Confusion or difficulty concentrating.
• Dizziness or faintness.
• Palpitations or feeling very hungry.

There are absolute contraindications you must not ignore.

Absolute Contraindications: Type 1 diabetes and diabetic ketoacidosis.

Do not take repaglinide if you have a known allergy to repaglinide or any excipients in the tablet.

Concomitant use of gemfibrozil is contraindicated because it can cause severe hypoglycaemia.

Use caution if you have liver or kidney problems and if you are elderly.

Start low and monitor closely when renal or hepatic impairment is present.

• Monitoring Steps: Regular blood glucose logs, including postprandial values.
• HbA1c checks per your clinician’s schedule.
• Baseline and periodic hepatic enzyme tests when liver disease is suspected.
• Periodic renal function tests if there is chronic kidney disease or reduced GFR.

Gluconorm is a Health Canada–approved product in Canada.

Approved packaging will show a Drug Identification Number (DIN) and include the patient leaflet.

• Packaging Checklist: Verify the DIN on the label.
• Check the strength (0.5 mg, 1 mg, or 2 mg) and expiry date.
• Confirm the manufacturer (Novo Nordisk on Gluconorm packs) and the bilingual patient leaflet where applicable.

High-Risk Groups

Who should be extra careful with repaglinide?

Elderly

Greater risk of hypoglycaemia and altered pharmacokinetics; start at the lowest dose and review frequently.

Pregnancy And Lactation

Use only under specialist advice; repaglinide is not indicated for type 1 diabetes and pregnancy decisions should involve obstetrics and endocrinology.

Indigenous And Remote Communities

Offer culturally safe counselling, coordinate with primary care and Indigenous health services, and ensure access to glucose testing supplies.

A brief culturally safe pointer: engage local health workers and respect community care plans when delivering diabetes education or titration instructions.

Interaction With Activities

Can repaglinide affect your ability to drive or operate machinery?

Yes—hypoglycaemia can impair reaction time, attention, and coordination.

If your job involves driving, heavy machinery, or safety-sensitive tasks, inform your employer according to provincial occupational health rules.

• Test blood glucose before driving if you have taken a meal dose within the prior two hours or if you feel off.
• Keep a quick snack or glucose tablets readily available in the vehicle or workplace.
• Carry extra blood glucose test strips and a meter at work.

Q&A — Can I Drive After Taking It In Canada?

Q: Can I drive after taking Gluconorm (repaglinide)?

A: Only if you are confident you are not hypoglycaemic.

Test blood glucose before driving if you have dosed within two hours of a meal or if you have any symptoms.

If blood glucose is below 4.0 mmol/L or you have symptoms such as sweating, dizziness or confusion, treat immediately and delay driving.

Notify your provincial driver licensing authority if required for medical conditions that affect driving.

• Checklist: Test.
• Treat if needed.
• Wait until you feel normal again and your blood glucose is back in range.
• Document symptoms and actions if your employer requires a report.

Usage Basics For Canadians

INN, Brand Names Available In Canada

What is this medicine called and how might you recognise it?

The INN is repaglinide, a rapid-acting meglitinide for type 2 diabetes.

• Gluconorm — Canada (tablets by Novo Nordisk).
• Prandin — United States (tablets 0.5 mg, 1 mg, 2 mg).
• NovoNorm — Europe (comparable dosage forms).

Packaging commonly comes in blister strips or bottles with a patient information leaflet in the local language.

Legal Classification Under Health Canada

Is repaglinide prescription or over the counter in Canada?

Repaglinide is prescription-only in all known territories, including Canada.

A valid prescriber’s order is required to obtain Gluconorm from licensed pharmacies.

Pharmacists in some provinces may provide counselling, limited renewals, or adapations within their scope.

Always check the DIN on approved products and avoid purchasing from unverified sellers.

• Pick-Up Checklist: Verify the medicine name and strength (0.5 mg, 1 mg, 2 mg).
• Read dosing instructions and take the patient leaflet home.
• Show your provincial drug plan card and ask about coverage or substitutions.

Canadian Dosing Guide

Standard Regimens (Health Canada Approved)

How is repaglinide dosed for adults?

Initial adult dosing commonly starts at 0.5 mg with each main meal when HbA1c is under 8%.

When HbA1c is 8% or higher, initial dosing may start at 1 mg with each main meal.

Dosage may be titrated weekly in response to glucose readings up to a single dose of 4 mg and a total daily dose of 16 mg.

Take repaglinide 0 to 30 minutes before meals to match insulin secretion to glucose influx.

• Titration Steps: Start 0.5 mg or 1 mg per main meal.
• Check meal-time and fasting glucose daily during titration and note hypoglycaemia events.
• Increase dose weekly if postprandial targets are not met, up to 4 mg per meal and 16 mg/day maximum.

Adjustments For Comorbidities

What changes are needed for kidney, liver disease, or older adults?

For renal impairment, begin at the lowest dose of 0.5 mg and titrate cautiously while monitoring for hypoglycaemia.

Repaglinide is contraindicated in severe hepatic impairment; use caution in mild to moderate liver disease and monitor liver enzymes.

Elderly patients are at higher risk of hypoglycaemia and should start low with individualized dosing and closer follow-up.

• Baseline And Follow-Up Checklist: Liver function tests before starting if liver disease suspected.
• Baseline renal function (serum creatinine, eGFR) and periodic monitoring.
• Regular HbA1c checks and review of home blood glucose logs.

Q&A — What If I Miss A Dose Under My Provincial Drug Plan?

Q: What should I do if I miss a meal dose and I’m concerned about pharmacy refills or coverage?

A: If you skip a meal, skip the corresponding repaglinide dose — do not double the next dose.

Contact your pharmacist or provincial drug-plan office for early refill exceptions or chronic disease program options under Ontario Drug Benefit, BC PharmaCare, RAMQ, or other plans.

Ask about generic repaglinide options versus Gluconorm to manage cost, and request medication synchronization if available.

Keep a medication diary and bring it to follow-up appointments to support coverage requests and dose adjustments.

Interaction Chart

Food And Drinks

How do common foods and drinks affect repaglinide?

Alcohol increases the risk of hypoglycaemia and may mask its symptoms.

Drink alcohol with caution and monitor glucose more closely when you plan to drink.

Caffeinated beverages can change appetite and the timing of meals, which may influence postprandial glucose.

Common Drug Conflicts

What medicines interact with repaglinide?

Gemfibrozil is a clear contraindication due to a high risk of severe hypoglycaemia when taken with repaglinide.

Drugs that inhibit CYP3A4 or CYP2C8 may increase repaglinide levels and raise hypoglycaemia risk.

Drugs that induce these enzymes may reduce repaglinide effect and require dose reassessment.

• Request a pharmacist-led medication review whenever new drugs are started.
• Contact your family doctor, nurse practitioner, or pharmacist for interaction checks.

Perform medication reconciliation at every care transition to reduce the chance of dangerous interactions.

• Interaction Screening Checklist: List all current prescription meds, OTCs, supplements and herbal products.
• Bring this list to every appointment and pharmacy visit.

User Reports & Trends In Canada

Canadian Patient Forums And Review Platforms

What are patients saying about Gluconorm in Canada?

Many patients report improved postprandial control and fewer mealtime spikes after switching to repaglinide.

Hypoglycaemia is the leading patient-reported adverse experience and the most common reason for dose adjustment.

Common patient-reported issues include timing the dose correctly, coverage and cost, and occasional gastrointestinal upset.

• Timing of dose (0–30 minutes pre-meal) is frequently mentioned in user discussions.
• Questions about affordability and drug-plan coverage are common on forums.
• Reports of improved daytime glucose control for people with irregular meals.

Community Pharmacy Feedback

What do pharmacists commonly advise when dispensing repaglinide?

Pharmacists emphasise correct timing, hypoglycaemia action plans, and synchronizing refills to improve adherence.

They often recommend providing a glucose meter and teaching patients to record postprandial readings.

Forum data is anecdotal and should not replace clinical advice.

Always consult your healthcare team for medication decisions.

Access & Purchase Options

National Pharmacy Chains

How do you get Gluconorm in person?

Gluconorm prescriptions are filled at major chains like Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu, with in-store pharmacist counselling.

In Quebec and some parts of New Brunswick and Ontario, bilingual service is available.

• How To Obtain: Bring a valid prescription, photo ID and your provincial drug plan card.
• Ask the pharmacist to confirm the DIN, brand and strength before leaving the counter.

In our online pharmacy, gluconorm is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Online Pharmacies In Canada & Provincial Restrictions

How to buy safely online?

Use CIPA-accredited or provincial college-licensed pharmacies to ensure legitimacy and Canadian DIN verification.

Avoid international sellers that don’t show a Canadian DIN or a licensed pharmacist contact.

• Safe Online Purchase Checklist: Verify pharmacy licence and contact details.
• Confirm DIN and product manufacturer (Novo Nordisk for Gluconorm).
• Ask for pharmacist counselling and eClaims compatibility with your provincial drug plan.

Standard shipping is suitable; repaglinide tablets do not require cold-chain handling.

Mechanism & Pharmacology

Simplified Explanation

How does repaglinide work so fast at mealtimes?

Repaglinide is a rapid-acting meglitinide that stimulates pancreatic beta cells to release insulin around meals.

Because it has a quick onset and short duration, it targets postprandial glucose spikes without a long-lasting insulin effect.

INN

Repaglinide

Class

Meglitinide (glinide)

ATC

A10BX02

A suggested diagram for patient education: meal → take repaglinide dose 0–30 min before → insulin peak shortly after → reduced postprandial glucose rise.

Clinical Terms

Important pharmacology notes to remember.

Repaglinide undergoes hepatic metabolism and has clinically relevant CYP-mediated interactions.

The short half-life means timing to the meal is critical for both efficacy and safety.

For authoritative details consult the Health Canada product monograph or Novo Nordisk product information.

Indications & Off-Label Uses In Canada

Approved Indications (DIN)

Who is repaglinide approved for in Canada?

Repaglinide is indicated as an adjunct to diet and exercise for adults with type 2 diabetes to control postprandial hyperglycaemia.

• Typical eligible patients include those with irregular mealtimes or intolerance to metformin.
• Prescription-only status applies; the DIN will be listed on approved packaging.

Common Off-Label Practices

Do clinicians ever use repaglinide outside the label?

Some clinicians may use repaglinide in carefully selected, justified off-label combinations with other oral agents when sulfonylureas are not tolerated.

Off-label use should be documented, agreed with the patient, and closely monitored for hypoglycaemia.

• Off-Label Decision Checklist: Review current evidence and rationale for use.
• Obtain informed consent and set a monitoring plan with frequent BG checks.
• Refer to a diabetes specialist when comorbidities are complex.

Key Clinical Findings

Canadian And International Studies 2022–2025

What does recent evidence say about repaglinide?

Recent studies confirm repaglinide’s effectiveness at reducing postprandial glucose excursions in adults with type 2 diabetes.

Head-to-head trials show benefit for patients with irregular meal patterns or those who cannot tolerate sulfonylureas.

Long-term cardiovascular outcome data are limited, so risk mitigation and monitoring remain important.

• Takeaway: Effective for mealtime spikes.
• Takeaway: Hypoglycaemia risk is real and must be proactively managed.
• Takeaway: Elderly patients require close follow-up.

Ongoing Health Canada Safety Monitoring

Health Canada conducts post-market surveillance and updates monographs or labelling as needed.

Clinicians and patients are encouraged to report adverse events through Health Canada’s MedEffect program.

Alternatives Matrix

Comparable Medicines With DIN In Canada

What other options exist for mealtime or overall glucose control?

Pros And Cons Checklist

• Consider efficacy for postprandial control versus hypoglycaemia risk.
• Assess renal and hepatic function before choosing and during therapy.
• Factor cost and provincial coverage into the shared decision-making process.
• Use a trial period with a blood glucose log and a follow-up review to confirm benefit.

Common Questions From Canadian Patients

How quickly does repaglinide work?

Take it 0–30 minutes before a meal; its effect is rapid and short-lived, targeting post-meal glucose.

Can I mix repaglinide with insulin?

Combining with insulin or other secretagogues increases hypoglycaemia risk and should only be done under specialist supervision.

Is repaglinide safe for seniors?

Use caution; start at the lowest dose and monitor closely for low blood sugar.

What if I drink alcohol?

Alcohol increases hypoglycaemia risk and can mask symptoms; avoid excessive drinking and monitor glucose closely.

• When To Call Your Healthcare Provider: recurrent hypoglycaemia, severe GI symptoms, or signs of allergic reaction.
• Bring medications to appointments for reconciliation and show your glucose log for dose review.

Local resources include provincial diabetes education centres, pharmacy diabetes programs and Telehealth services for advice and support.

Coverage & Purchase Comparison Table

Comparison Table — Province/Plan, Coverage Status, Typical Patient Cost, Prescription Required

Coverage varies by province and plan; verify exact details with provincial formularies or your pharmacy benefits desk.

Do not rely on published copay figures here; contact your provincial plan or pharmacy to confirm the current cost and any prior authorization needs.

Step-By-Step Purchase Checklist For Canadian Patients

• Obtain a current prescription from your prescriber.
• Bring provincial ID and drug-plan card to the pharmacy.
• Confirm the DIN, brand (Gluconorm) or generic repaglinide and the strength with the pharmacist.
• Ask about generic options, patient assistance programs and medication synchronization.
• Request a blood glucose meter, test strips and a hypoglycaemia action plan if needed.
• Contact provincial formulary or benefits staff for prior-authorization processes when required.

Registration & Regulation

Health Canada Approval

Gluconorm (repaglinide) is approved by Health Canada for use in Canada.

Approved products carry a DIN and meet national labelling and quality standards.

Health Canada maintains post-market surveillance and updates labels or warnings if new safety data emerge.

DIN Number And Labelling Requirements

What does the DIN mean for you?

The DIN is a unique identifier linking the package to Health Canada’s product file and approval.

Some regions require bilingual labelling and a patient information leaflet inside the packaging.

Typical storage instructions on the label indicate storage at 25°C with permitted excursions of 15–30°C.

DIN

Drug Identification Number, a Health Canada identifier.

Monograph

Official product information and approved indications.

MedEffect

Health Canada’s adverse event reporting system.

Always check the DIN and expiry date before leaving the pharmacy.

Storage & Handling

Standard Canadian Household Conditions

How should you store repaglinide tablets at home?

Store tablets at 25°C (77°F) with allowed excursions between 15–30°C (59–86°F).

Keep tablets in their original blister or bottle and protect from moisture and heat.

Store out of reach of children and pets and use child-resistant caps where provided.

• Keep medicine in a cool, dry cabinet—avoid storing in bathrooms.
• Do not transfer tablets to unlabeled containers.

Cold-Chain Requirements

Do repaglinide tablets need refrigeration?

No refrigeration is required for repaglinide tablets and refrigerating may increase moisture exposure.

Pharmacies typically ship tablets using standard insured shipping rather than cold-chain methods.

• Travel Checklist: Carry tablets in original packaging and bring a prescriber’s letter if crossing borders.
• Carry a small blood glucose kit with spare batteries and glucose tablets for emergencies.

Guidelines For Proper Use

Canadian Pharmacist Guidance

What will the pharmacist discuss when dispensing Gluconorm?

Pharmacists will review timing (take 0–30 minutes before meals), hypoglycaemia recognition and response, and important interactions such as the gemfibrozil contraindication.

They will confirm renal and hepatic status and help with drug-plan coverage and adherence supports.

• Pharmacist Counselling Template: Verify current medications and allergy history.
• Set blood glucose targets and a hypoglycaemia action plan.
• Arrange follow-up for dose titration and monitoring.

Provincial Health Authority Recommendations

Follow provincial diabetes management algorithms and refer to diabetes education centres for structured self-management training.

Suggested follow-up timeline: phone check 1–2 weeks after start or dose change, HbA1c at 3 months, and routine annual reviews.

• Schedule dose titration reviews and bring blood glucose logs to appointments.
• Coordinate with a multidisciplinary team including pharmacist, PCP and diabetes educator when appropriate.

Delivery Across Canada (English)